Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease

Background and objectives: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, reduces bioavailability of nitric oxide and induces endothelial dysfunction. This dimethylated amino acid accumulates in chronic kidney disease and may be involved in the pathophysiology...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Young, Jill Melendez, Terrin, Norma, Wang, Xuelei, Greene, Tom, Beck, Gerald J., Kusek, John W., Collins, Allan J., Sarnak, Mark J., Menon, Vandana
Format: Artigo
Langue:Inglês
Publié: American Society of Nephrology 2009
Sujets:
Epidemiology and Outcomes
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689879/
https://ncbi.nlm.nih.gov/pubmed/19389824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06671208
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires